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1. Introduction
Over the course of this report1 we assess the current state of patent litigation in the UK’s largest 
jurisdiction for patents, England and Wales. This is in light of the fact that the Uniied Patent Court 
(UPC) – a new, unique patent court for 25 participating European jurisdictions, including the UK – 
due to come into being during 2016.2 Providing this assessment at this time is important because UK 
businesses, lawyers and policy-makers are currently making their preparations for the UPC.
At present England and Wales is home to one of the major patent courts in Europe - the Patents 
Court (PHC) – as well as an accessible venue for smaller-value patent disputes – the Intellectual 
Property Enterprise Court (IPEC).3 Importantly, both courts currently have the jurisdiction to decide 
matters relating to UK-granted patents (GBs) as well as European patents validated in the UK (EPs). 
However, the advent of the UPC and the European Patent with unitary effect (the Unitary Patent, or 
UP) is likely to impact upon the patent litigation strategies of UK businesses, particularly with respect 
to choice of litigation venue.4
In this regard, UK businesses face a dificult decision: should they or should they not seek to obtain 
UP protection? Finding the right answer to this question is important because if UK businesses and 
inventors choose to obtain UPs – rather than GBs or the traditional EPs – then they will not be able 
to undertake litigation at national venues such as the PHC or IPEC; instead, they will have to take 
cases to the UPC, which will have sole jurisdiction to hear crucial UP matters such as infringement 
and validity. 
For UK patentees holding EPs there is another crucial decision to make: whether or not to opt-out 
their existing EP portfolios from the UPC’s jurisdiction. This opt-out may occur during the transition 
period -currently expected to last for at least 7, and potentially extendable to 14, years. If an EP is 
opted-out of the UPC during the transition period, the national courts will remain the sole litigation 
venue, a situation which lasts for the lifetime of that patent. Separately, during the transition period, 
national courts such as the PHC and IPEC will share jurisdiction with the UPC with respect to EPs 
that have not been opted-out. In addition, it is worth noting that the UPC will not have jurisdiction 
over nationally granted patents i.e. GBs, which will remain within the sole jurisdiction of national 
courts. UK businesses, therefore, will soon face a choice between three different ways of protecting 
their patents - GB, EP or UP - with the choice they make affecting potential litigation venues.
As explored below, until recently there has been a distinct lack of accurate quantitative data 
concerning patent cases iled at the PHC and IPEC. In fact, until the publication of this report it was 
not even possible to say with accuracy how many patent cases were iled in any given year at the 
PHC and IPEC, a signiicant gap in our knowledge. Following an exhaustive data-gathering and 
analysis process which took place, mainly at the Rolls Building in London, from May 2013-October 
2014 this report represents the irst authoritative account of patent litigation undertaken at the PHC 
and IPEC, covering all cases iled during the period 2007-2013. In this report, we provide detailed 
data on the overall volume of patent litigation undertaken at the PHC and IPEC, as well as on the 
types of litigants and the litigated patents (including the proportion of EPs and GBs that are litigated 
1 We acknowledge inancial support from the UK Intellectual Property Ofice.  The authors thank Shane burke, Francesco 
Dionisio, Leslie Lansman, Manuel Rey-Alvite Villar and Paula Westenberger for outstanding research assistance.
2 Agreement on a Uniied Patent Court 2013/C 175/01 (http://eurlex.europa.eu/LexUriServ/LexUriServ.
do?uri=OJ:C:2013:175:0001:0040:EN:PDF)
3 See Cremers et al. (2013).
4 Regulation (EU) No 1257/2012 of the European Parliament and of the Council of 17 December 2012 implementing enhanced 
cooperation in the area of the creation of unitary patent protection; Council regulation (EU) No 1260/2012 of 17 December 
2012 implementing enhanced cooperation in the area of the creation of Unitary patent protection with regard to the applicable 
translation arrangements -- both documents accessible at the http://ec.europa.eu/internal_market/indprop/patent/
documents/index_en.htm. For a further explanation of the changes see the EPO website (http://www.epo.org/law-practice/
unitary.html). See also Romandini and Klicznik (2013) and Brandi-Dohrn (2012).
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at each court each year).5 The provision of these data is useful for businesses, policy-makers and 
lawyers because it is likely that the coming into being of the UPC will have an impact on the amount 
and types of cases taken at the PHC and IPEC; as such, having an accurate picture of the current 
situation makes it easier for businesses, policy-makers and law irms to align themselves with the 
new patent environment. This will include a London-based UPC Central Division with the jurisdiction 
to hear cases concerning pharmaceutical and chemical patents.
The remainder of this report is organized as follows. Section 2 describes the data collection and 
Section 3 provides the statistics and analysis. Section 4 offers some concluding remarks concerning 
the overall signiicance of the data viz. the coming into being of the UPC.
5 Our data and analysis refer solely to the jurisdiction of England and Wales, the UK’s largest patent jurisdiction. We do not 
include case data from Scotland or Northern Ireland.
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2. Data Gathering Methodology
In order to examine patent litigation at the PHC and IPEC in detail, it was necessary to collect 
detailed information about patent cases iled at both courts for the period 2007-2013. We proceeded 
as follows: irst we evaluated the available published empirical research on the topic; second we 
drew lessons from our experience of analysing patent case-level data (Helmers and McDonagh 
2013a); thirdly, we obtained access to the physical court records at the Rolls Building in London. As 
detailed below, for this project collecting and analyzing data from the physical iles was an imperative 
because information on all patent case ilings is not available online; indeed, the primary publicly 
available source – the Patents Court Diary – does not list information on all cases iled, merely all the 
cases for which a hearing has been scheduled.
Literature review and assessment of prior projects
With respect to the published literature, it is clear that for much of the recent past there has been 
little available empirical evidence on patent litigation in the UK (Weatherall et al., 2009). However, in 
recent years several studies have been published. For instance, Moss et al. (2010) examine the 
outcomes of a sample of 47 validity and infringement cases undertaken between January 2008 and 
August 2009 at the IPEC, the PHC, the Court of Appeal, and the House of Lords. Helmers and 
McDonagh (2013a) offer a more comprehensive analysis that covers all patent cases iled/heard at 
the PHC between 2000 and 2008 for which some information was publicly available, as well as all 
patent cases decided at the IPEC in 2007 and 2008. In a further paper based on this dataset Helmers 
and McDonagh (2013b) also discuss how the costs of patent litigation are allocated between the 
litigating parties. In addition to the court data, Greenhalgh et al. (2010) collected survey data on a 
small sample of patenting and non-patenting companies (alive between 2002 and 2009) in order to 
analyse the IP litigation activity of micro irms and SMEs. We took into account the indings of the 
above papers when designing our methodological approach to this project, particularly noting that 
none of the above papers contains a complete dataset drawn from the relevant physical court 
records – in each case either the available online records or a very limited dataset is used.
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Patent cases at the IPEC (formerly the PCC)
In the context of the IPEC, it is worth noting that in our prior research we analysed anonymised case-
level data provided to us by the UK IPO for all IP cases decided in 2007 and 2008 (Helmers and 
McDonagh 2013a). Due to the limitations of these data, it was necessary as part of this project to 
collect detailed information on all patent cases iled at the IPEC for the entire period 2007-13.
In order to be able to analyse all IPEC patent cases iled during this period – and to provide the 
requisite data to the IPO – we developed the following methodology: irst, we – along with a team of 
research assistants – collected and compiled the physical IPEC court records/iles and associated 
information held at the Rolls Building for patent cases iled 2007-13; secondly, we used a specially 
devised patent-speciic excel spreadsheet to extract and organize the relevant information gathered 
from these often extremely detailed and complex records; thirdly, we analysed these data in order to 
produce reliable statistics. These irst two tasks were made possible in part thanks to the assistance 
we received from the IPEC clerk, as well as Hacon J. and Birss J., who helped us to compile lists of 
relevant cases from the IPEC Diary and other internal court sources. However, a small proportion of 
the IPEC case iles are regularly missing from the IPEC clerk’s iling system at any given time due to 
the fact that case iles are needed at IPEC trials. For this reason, the research assistants frequently 
did a sweep of the IPEC iling system to see if missing iles had been returned, which helped us to 
locate the vast majority of cases which were not immediately accessible to us.
Nonetheless, the record keeping at the IPEC remains largely paper-based – rather than digital – and 
as such, it is not possible to keep track of or locate every ile within the system. For this reason there 
are a very small number of IPEC cases for which were unable to obtain any information except for 
the case ile number. Nonetheless, we are conident that, given the methodical approach we took to 
case-counting during September 2013-July 2014, and the frequent sweeps we took of the IPEC 
records to search for missing cases, we have examined every possible physical IPEC patent case ile 
for 2007-13. On this point, it is further worth noting that in September 2014 we examined the available 
IPEC patent judgments for 2007-13 online (via BAILII); importantly, we did not ind any cases that we 
did not already have a record of from our search of the physical iles. In other words, our data were 
collected from paper records at the Rolls Building during the period September 2013-July 2014, with 
further online data gathering in September 2014. Thus, our IPEC patent claim dataset includes data 
drawn from all physical iles available at the Rolls Building and all available digital court records; as 
such, it is as complete as possible. 
For IPEC patent cases, the information that we possess includes data on the amount of cases iled, 
the types of claims and counter-claims made (infringement, validity etc.), the types of litigants, and 
the relevant patents in dispute (EP numbers, GB numbers etc.). These data are analysed below in 
section 3.
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Patent cases at the PHC
Regarding the PHC, as with the IPEC cases, our aim was to collect data on all patent cases iled 
during 2007-13. In order to ensure consistency with our IPEC data, we followed largely the same 
methodology as above: irst, we collected and compiled the physical PHC court records/iles and 
associated information held at the Rolls Building for patent cases iled 2007-13; secondly, we used 
a specially devised patent-speciic excel spreadsheet to extract and organize the relevant information 
gathered from these PHC case iles.
However, while the IPEC records from 2007-13 are held within a speciied area solely allocated to 
IPEC iles – and there is a speciic IPEC Clerk that assisted us – the PHC iles are not held separately 
from the regular Chancery Division case iles; nor is there a list of all available PHC case ile numbers 
which would enable researchers to easily locate a case. As a result, the only way to count and 
examine PHC iles is to physically go through the estimated ive thousand Chancery Division cases 
that are iled each year, opening each ile to see if it is a PHC claim or another Chancery matter (e.g. 
a property dispute, an insolvency claim etc.).
Given the challenges of counting and examining PHC patent case iles, and in consideration of our 
overall aim of obtaining a complete dataset, in addition to the physical count we developed an 
additional multi-pronged approach:
• For the years 2011 and 2012, the law irm Powell-Gilbert provided us with a list of case ile 
numbers from a physical search of iles they had undertaken during early 2013. These numbers 
helped us to identify the 2011 and 2012 PHC iles, though we also undertook a complete search 
of all Chancery iles for these years in order to ensure we covered every possible case, which 
enabled us to verify and on a few occasions make minor corrections to the Powell-Gilbert 
numbers.
• In order to ensure we did not miss any physical iles during our search i.e. iles that were not in 
the basement but which were instead in active use at trial, we used the Patents Court Diary in 
order to cross-reference the listed cases with what we found in the physical records. For any 
cases listed in the diary that we did not ind in our initial search, we returned to the basement on 
a number of occasions in order to see whether the case had been re-iled. We located a number 
of missing case iles in this way.
• We liaised with HMCTS regarding their annually collected and published records showing the 
amount of PHC cases iled per year. We attempted to use these as a comparative guide to our 
search. Unfortunately, there is no way to directly verify the HMCTS statistics as HMCTS do not 
link the raw data with actual case ile numbers (and as such there is no way to methodically 
search for all of these apparently iled cases).6 The methodical search we undertook of all 
Chancery iles is the only way to actually verify how many PHC patent cases are iled each year 
(the vast majority of PHC cases are patent cases, rather than e.g. registered design cases). On 
the completion of our search, we discovered discrepancies between the number of case iles we 
actually found and the published HMCTS statistics. Having discussed the issue with several 
HMCTS staff, we came to the conclusion that the HMCTS published statistics are not reliable. 
In light of the methodological approach we took, we are conident that our numbers are a better 
relection of the amount of cases iled per year, and are more reliable than the published HMCTS 
numbers.
• HMCTS informed us that some 2007 Chancery iles were destroyed in a ire during 2008. 
Unfortunately HMCTS could not give us any more information as to which iles were destroyed. 
As a result our PHC numbers for 2007 have to be treated cautiously as it is likely some PHC 
case iles were destroyed before we could examine them. (However, there are no such worries 
for the 2008-13 iles.)
6 Note that at the request of Birss J. from 2013 in its record keeping HMCTS has kept data on PHC ilings separate from 
IPEC ilings, something that has increased the accuracy of the statistics viz. our own records (though the HMCTS statistics 
are still not entirely reliable, and still not linked to actual case ile numbers).
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• As with the IPEC, from September-October 2014 we examined the available PHC patent 
judgments for 2007-13 online (via BAILII). This was useful, as we found a small number of cases 
for 2007-13 that were missing from our dataset (taken from the physical records). We then 
collected data from the online judgments and added these cases to our overall dataset. Thus, 
as with the IPEC, while there are a very small number of PHC patent cases for which we are 
missing data, we are conident that our PHC dataset comprehensively includes all available 
physical and online records; as such it is as complete as possible.
For PHC patent cases, as with the IPEC, the information that we possess includes data on the 
amount of cases iled, the types of claims and counter-claims made (infringement, validity etc.), the 
types of litigant, and the relevant patents in dispute (EP numbers, GB numbers etc.). These PHC 
data were collected from September 2013-October 2014 and are analysed in detail in section 3 
below.
Gathering firm-level data on PHC and IPEC litigants
We obtained the names of all litigating parties from the court records as described above. We irst 
cleaned and standardised these names as they often appear in different ways on different court 
records. In a second step we classiied litigants into 3 categories: (i) companies, (ii) individuals, and 
(iii) government, universities and not-for-proit. In a third step, we searched for all companies on the 
Companies House online database WebCheck as well as Bureau van Dijk’s FAME database. We 
obtained basic information on companies from Companies House (SIC code, incorporation date, 
current status etc.) and detailed inancial information from FAME (assets, turnover, employees etc.). 
The combination of information from Companies House and inancial data from FAME allowed us to 
classify companies into size categories (micro, SME, large), something which enables us to discuss 
company size-speciic litigation issues in section 3 below.7
7 We follow the standard EU deinition, which relies on information on a irm’s number of employees, turnover, and total assets 
(http://ec.europa.eu/enterprise/policies/sme/facts-igures-analysis/sme-deinition/index_en.htm).
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3. Statistics
IPEC case counts
Table 1: PCC/IPEC: case counts, 2007-2013
Year
Case 
count
Cases 
with EP 
Cases 
with EP 
involving 
UK firm
Number 
of UK 
firms 
involved 
in cases 
with EP 
Cases with EP 
involving UK 
SME
% Cases with EP 
involving UK SME
Cases 
with EP 
involving UK 
defendant
  (1) (2) (3) (4) (5) (6) (7)
2007 6 2 2 5 2 33.33% 2
2008 4 3 3 7 3 75.00% 3
2009 8 4 4 6 4 50.00% 3
2010 8 5 5 10 5 62.50% 5
2011 27 13 13 27 11 40.74% 13
2012 26 11 8 17 8 30.77% 8
2013 17 9 9 19 8 47.06% 9
Total 96 47 44 91 41 42.71% 43
Notes: patent numbers missing for 1 case in 2007, 1 case in 2009, and 1 case in 2011; information on litigating parties missing for 1 case in 
2007 and 1 case in 2011.
Table 1 provides case counts for the PCC/IPEC for 2007-2013. A total of 96 patent cases were iled at the IPEC during 
the 7-year period. However, the more relevant number for the purposes of the UPC relates to cases that centre on an 
EP – these are shown in column (2) (there are a total of 47 such cases). It is worth giving consideration to these IPEC 
EP cases because these are cases that in future years could potentially fall within the jurisdiction of the UPC. On this, 
it is worth recalling a number of points made above: irst, for a seven year transition period (which may eventually be 
extended by another seven years) patentees holding EPs will be able to opt-out of the UPC’s jurisdiction (an opt-out 
which will last for the lifetime of that patent); secondly, for patents that are not opted out of the UPC’s jurisdiction it 
will be possible to take a case at either a relevant national court venue – such as the IPEC – or at the UPC; thirdly, if 
a patentee decides to obtain a UP, it will not be possible to undertake patent litigation concerning that UP at national 
venues such as the IPEC – litigation must take place at the UPC. Finally, after the transition period ends, patentees 
will no longer be able to opt-out EPs from the UPC’s jurisdiction – the UPC will become the sole venue for all EP and 
UP litigation (excluding litigation concerning EPs which have already been opted-out).
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SME EP litigation at the IPEC
As noted above, for all UK companies the decision whether to opt-out their existing EP portfolios 
from the UPC will be an important one. Moreover, this decision is of particular signiicance for SMEs 
because losing access to the IPEC will obviously have litigation cost ramiications, though the UP 
and UPC will of course have the advantages of enabling wider protection within Europe, something 
that could bring commercial and inancial beneits (McDonagh, 2014).
In this regard, knowing the share of UK SMEs involved in IPEC EP ligation during 2007-2013 can 
help us to assess the popularity of the venue for SMEs.  From our data we observe that at present a 
large share of IPEC patent cases feature UK companies – and that UK SMEs are frequently involved. 
Column (3) shows the number of patent cases for 2007-2013 that feature both an EP and a irm 
registered in the UK; meanwhile, column (4) shows the corresponding number of irms registered in 
the UK. We observe that in 44 out of 47 EP-centred cases a UK irm was an active party, and of these 
cases a total of 91 UK irms were involved. Regarding SMEs, column (5) shows the number of EP 
cases that involve a UK SME – 41. Of further note is column (6) which shows the corresponding SME 
share of the total number of patent cases (column (1)), illustrating the difference in SME share over 
time as the overall number of patent case ilings has increased (an increase which appears to have 
occurred largely since the coming into force of the IPEC reforms 2010-2013). Finally, column (7) 
shows the case count for cases where at least one defendant is registered in the UK.
Overall, the data suggest that since 2010 UK companies, including SMEs, have increasingly availed 
of the IPEC for patent litigation concerning their EPs. Although we cannot draw irm conclusions 
from this about future SME litigation behaviour, it seems likely that the availability of low cost UK-
based patent enforcement at the IPEC for EPs will play a part in many SMEs’ considerations regarding 
(i) the decision whether to opt-out EPs from the UPC and (ii) the decision whether to seek to obtain 
UPs. Indeed, SMEs that prize low cost UK enforcement over more costly Europe-wide enforcement 
may choose to opt their EPs out of the UPC and continue to litigate at the IPEC (McDonagh, 2014).
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Analysing IPEC litigation involving companies in different business 
sectors
Table 2: PCC/IPEC: case counts across industries (case counts involving EPs/GBs), 2007-2013
Year SIC available life sciences
mechanical 
engineering all others
involving UK 
defendant not life 
sciences
  EP GB EP GB EP GB EP GB EP GB
  (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
2007 2 2 0 1 1 1 2 2 2 1
2008 3 1 0 0 0 0 3 1 3 1
2009 4 3 1 0 1 1 2 2 2 3
2010 4 3 0 0 1 0 3 3 4 3
2011 13 12 2 0 4 4 12 10 11 12
2012 8 14 0 3 2 3 7 13 8 10
2013 9 8 0 1 3 0 8 7 9 7
Total 43 43 3 5 12 9 37 38 39 37
Notes: patent numbers missing for 1 case in 2007, 1 case in 2009, and 1 case in 2011; information on litigating parties missing for 1 case in 
2007 and 1 case in 2011.
Table 2 offers a breakdown of UK registered companies for cases that involve an EP and/or a GB across broad 
industry categories.8 Columns (1) and (2) show the number of cases for which we have information on a company’s 
SIC code (this information comes from Companies House) for cases involving EPs and GBs respectively; meanwhile, 
columns (3)-(8) break the count down into (i) life sciences, (ii) mechanical engineering, and (iii) other (for more 
information see the appendix). Finally, columns (9) and (10) show the number of cases that involve UK defendants 
outside of the life sciences.
Notably, very few UK life sciences companies were involved in litigation at the IPEC during 2007-2013 regardless of 
whether we focus on cases that involved an EP or GB. This can be contrasted with the relatively high number of such 
cases involving EPs at the PHC (as shown below) and it may indicate that life sciences cases are unsuited to the IPEC 
due to issues such as complexity, costs, and overall case value.
8  Cases can involve both GBs and EPs.
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PHC Case counts
Table 3: PHC: case counts, 2007-2013
Year
Case 
count
Cases 
with EP 
Cases 
with EP 
involving 
UK firm
Number 
of UK 
firms 
involved 
in cases 
with EP 
Cases with EP 
involving UK 
SME
% Cases with EP 
involving UK SME
Cases 
with EP 
involving UK 
defendant
  (1) (2) (3) (4) (5) (6) (7)
2007 33 27 22 31 8 24.24% 21
2008 71 65 50 69 21 29.58% 50
2009 49 38 30 43 17 34.69% 29
2010 50 42 29 43 14 28.00% 29
2011 92 77 55 66 18 19.57% 54
2012 89 75 44 44 17 19.10% 43
2013 61 48 41 43 11 18.03% 41
Total 445 372 271 339 106 23.82% 267
Notes: information on litigating parties missing for 2 cases; patent numbers not available for 17 cases.
Table 4: PHC: case counts across industries (case counts involving EPs/GBs), 2007-2013
Year SIC available life sciences
mechanical 
engineering all others
involving UK 
defendant not life 
sciences
  EP GB EP GB EP GB EP GB EP GB
  (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
2007 22 7 12 0 1 2 10 6 9 7
2008 50 6 11 1 4 0 39 6 39 5
2009 30 8 13 0 3 2 18 8 16 8
2010 29 7 10 1 7 3 18 5 19 6
2011 55 12 15 1 7 4 40 9 39 10
2012 44 10 18 3 3 4 26 6 26 7
2013 40 7 22 0 3 2 19 7 18 7
Total 270 57 101 6 28 17 170 47 166 50
Notes: information on litigating parties missing for 2 cases; patent numbers not available for 17 cases. 
Tables 3 and 4 give the case count igures for the PHC. Table 3 shows that there were 445 patent cases iled at the 
PHC during 2007-2013, demonstrating that the majority of patent litigation takes place at the PHC rather than at the 
IPEC, even post-IPEC reforms. Again, for UPC opt-out considerations it is worth noting that a large proportion of 
these cases – 372, in fact – concern an EP. Meanwhile, Table 3 shows that 271 of the PHC cases that centre on an 
EP involve a UK irm.
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SME EP litigation at the PHC
Interestingly, our data show that many more UK SMEs (106) were involved in EP litigation at the PHC 
during 2007-2013 than at the IPEC (though it is worth noting that a large number of these PHC cases 
took place pre-IPEC reforms, and that the IPEC is a much more popular venue post-reforms). Overall, 
almost a quarter of all PHC cases concerning one or more EPs featured an SME as a case party. 
While this share is signiicantly lower than the share of SME litigation at the IPEC, it is by no means 
an insigniicant proportion. Furthermore, it indicates that many SMEs are acutely familiar with the 
(relative to the IPEC) high-cost litigation that occurs at the PHC – something that may inluence their 
decision whether or not to opt-out the UPC system.
Analysing PHC litigation involving companies in different 
business sectors
Regarding Table 4, it is clear that a far greater proportion of life sciences patent cases occur at the 
PHC than at the IPEC. Notably, these cases involve, almost exclusively, EPs. By contrast, there are 
comparatively few mechanical engineering cases – an area that will come under the jurisdiction of 
Munich’s UPC Central Division – and unlike the life sciences patents, which are mostly EPs, there is 
a more even spread of EPs and GBs with respect to the mechanical engineering patents.
The large share of life sciences EP litigation that occurs at the PHC is of interest because the London-
based UPC Central Division will have jurisdiction to hear cases – mainly with respect to validity 
issues – concerning life sciences EPs (pharmaceuticals and chemicals) unless the EP is opted-out 
(and it will also have sole jurisdiction with respect to life sciences UPs). After the transitional period, 
the UPC London Central Division will have sole jurisdiction to hear life sciences EPs cases (unless a 
particular EP has already been opted-out - as noted above, opt-outs will last for the lifetime of the 
patent). Given the fact that London is perceived as a ‘hub’ in the area of life sciences – with respect 
to both scientiic and legal expertise – it will be interesting to see in the coming transitional years 
whether life sciences companies based in the UK continue to use the PHC as their primary forum of 
patent litigation, or whether they make use of the London-based UPC Central Division either as an 
alternative venue to the PHC (for EPs) or as the sole venue (for UPs).
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PHC and IPEC Patent-level comparison
Figure 1: IPEC/PHC: EP counts by year (cases with revocation and/or infringement claims), 2007-
2013
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Figure 1 compares the total number of EPs involved in cases at the IPEC and the PHC by year over 
the entire 2007-2013 period.9 As would be expected given the much larger number of cases litigated 
at the PHC, the number of EPs litigated at the PHC is by many multiples larger than the number at 
the IPEC. Nonetheless, it is interesting to note that there was a substantial increase in the number of 
EPs litigated at the IPEC during 2011, with their number almost tripling relative to 2010. Although 
there is also a noticeable increase in patent case numbers between 2010 and 2011 at the PHC, the 
increase was not as steep as in the case of the IPEC. We observe that the number of EPs litigated at 
the PHC per year varies considerably between 2007-2013, with 2011 seeing the most EP litigation 
overall when the igures for both the PHC and the IPEC are taken into account.10
9 Note that we count each patent only once, that is, if a given patent appears in several cases in a given year, it is counted 
only once.
10 It is worth bearing in mind the caveat explain in section 2 - that the data for the PHC might be incomplete for 2007.
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PHC and IPEC Case-level comparison
In addition to the case counts given above, we also provide case counts broken down by claim and 
counter-claim type (where again we distinguish between cases that involve EPs and GBs). Tables 5 
and 6 show the breakdown by revocation and infringement claims for the IPEC and the PHC. Tables 
7 and 8 show the corresponding igures for counterclaims at both courts. The tables demonstrate 
that the most common initial claim at both the IPEC and the PHC is for infringement regardless of 
whether we focus on EPs or GBs. In addition, a signiicant number of initial revocation claims – 
aimed at ‘clearing the way’ for a possibly infringing product – are iled at the PHC, with revocation 
also being a frequent counter-claim. Notably, very few revocation claims are iled at irst instance at 
the IPEC. This might be explained by two things: (i) the complexity of many revocation issues; and 
(ii) the remit of the IPEC, especially its limitations on disclosure, expert evidence and the amount of 
hearing days. Nonetheless, revocation is a frequent counter-claim at the IPEC, illustrating that the 
IPEC is capable of dealing with this issue.
Table 5: PCC/IPEC: case counts by claim (EPs and GBs), 2007-2013
Claim
Year Revocation Infringement Other
EP GB EP GB EP GB
  (1) (2) (3) (4) (5) (6)
2007 0 0 2 3 0 0
2008 0 0 2 0 1 1
2009 0 0 4 3 0 0
2010 0 2 5 1 0 0
2011 0 4 12 7 1 1
2012 3 1 7 12 1 2
2013 1 0 6 8 2 0
Notes: total number of EP cases, 47, and GB cases, 45. Totals per row may exceed total number of cases as (a) multiple 
claims possible and (b) cases may include both EPs and GBs.
Table 6: PHC: case counts by claim (EPs and GBs), 2007-2013
Claim
Year Revocation Infringement Other
EP GB EP GB EP GB
  (1) (2) (3) (4) (5) (6)
2007 16 3 7 4 5 1
2008 19 2 43 5 6 2
2009 18 0 18 8 3 0
2010 23 2 18 6 3 0
2011 31 1 39 10 9 2
2012 39 2 30 9 6 2
2013 19 1 22 7 7 0
Notes: total number of EP cases, 372, and GB cases, 65. Totals per row may exceed total number of cases (a) multiple 
claims possible and (b) cases may include both EPs and GBs. 
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Table 7: PCC/IPEC: case counts by counter-claim (EPs and GBs), 2007-2013
Counter-claim
Year Revocation Infringement No counterclaim Other
EP GB EP GB EP GB EP GB
  (1) (2) (3) (4) (5) (6) (7) (8)
2007 0 0 0 0 2 3 0 0
2008 2 0 0 0 1 0 0 1
2009 2 2 0 0 2 1 0 0
2010 3 2 0 0 2 1 0 0
2011 9 4 1 1 3 7 0 0
2012 5 7 3 3 3 3 0 2
2013 2 4 0 0 7 4 0 0
Notes: total number of EP cases, 47, and GB cases, 45. Totals per row may exceed total number of cases (a) multiple 
claims possible and (b) cases may include both EPs and GBs. Other category includes for example declarations of non-
infringement or validity.
Table 8: PHC: case counts by counter-claim (EPs and GBs), 2007-2013
Counter-claim
Year Revocation Infringement No counterclaim Other
EP GB EP GB EP GB EP GB
  (1) (2) (3) (4) (5) (6) (7) (8)
2007 4 2 6 1 15 4 1 0
2008 30 2 6 0 21 4 4 1
2009 13 6 5 0 14 2 6 0
2010 12 5 9 2 15 2 7 1
2011 24 7 12 2 25 2 15 1
2012 10 5 15 1 33 5 17 1
2013 11 6 6 0 25 2 6 0
Notes: total number of EP cases 366 (no records available for 6 cases), GB cases 62 (no records available for 3 cases). 
Totals per row may exceed total number of cases as (a) multiple claims possible and (b) cases may include both EPs and 
GBs. Other category includes for example declarations of non-infringement or validity. 
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4. Conclusion
Our data show that 445 patent cases were iled at the PHC during 2007-2013, whereas a total of 96 
patent cases were iled at the IPEC during the same 7-year period. This demonstrates that the 
majority of patent litigation in the UK’s largest patent jurisdiction – England and Wales – takes place 
at the PHC rather than at the IPEC, even post-IPEC reforms. Nonetheless, we also observe that the 
amount of IPEC patent litigation has increased substantially post-reforms, while over the same 
period the PHC has not seen fewer cases – quite the opposite, in fact.
Regarding patent-level data, it is worth noting that a very large number of the PHC patent cases - 
372 - concern an EP, while at the IPEC 47 out of 96 patent cases centre on an EP. In other words, 
EPs tend to be the subject of PHC litigation much more frequently than GBs, but there is a more even 
split at the IPEC. In terms of case-level data, we show that infringement is the most common initial 
claim at both the PHC and IPEC; but that revocation is a frequent claim at the PHC and a frequent 
counter-claim at both courts. With respect to litigant-level data, we observe that more SMEs (106) 
were involved in PHC litigation than were involved in IPEC litigation (41) over the same period, a fact 
which shows that despite the increasing popularity of the IPEC, a large proportion of litigant SMEs 
are familiar with the PHC, something which may enter into their UPC opt-out considerations.
Looking ahead to the UPC, there is little doubt that the answers to two key questions - (i) whether 
UK irms will begin to opt for UPs, and thus litigate sole at the UPC for these patents and (ii) whether 
UK irms will decide to opt-out their EPs during the transitional period, and thus continue to solely 
conduct litigation concerning their EPs at the PHC/IPEC, will determine how substantial and 
immediate the impact of the coming into being of the UPC/UP will be felt with respect to the amount 
and types of cases iled at the PHC/IPEC. On the one hand, if patentees decide en masse to opt for 
UPs instead of EPs or GBs it would seem logical that there would be less litigation at the PHC and 
IPEC in the coming years. On the other hand, recent survey evidence suggests that not all current 
patentees are actually considering doing this in the early years of the new system; some are taking 
a ‘wait and see’ approach (McDonagh, 2014). Indeed, in the coming years patentees may decide to 
maintain a spread of different types of patents – GB, EP and UP – a decision that would leave 
multiple potential litigation venues open, and which in turn would mean that in the immediate term 
the current rates of patent litigation at the PHC and IPEC may not be drastically affected by the 
coming into being of the UPC. Ultimately, by providing an authoritative, data-driven account of 
patent litigation at the PHC and IPEC for the period 2007-2013 this report makes a useful contribution 
to current discussions concerning patent litigation within the UK and the wider EU.
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Appendix: Definitions of life sciences 
and mechanical engineering
Life sciences:
• SIC 21.1: Manufacture of basic pharmaceutical products;
• SIC 21.2: Manufacture of pharmaceutical preparations;
• SIC 26.6: Manufacture of irradiation, electromedical and electrotherapeutic equipment;
• SIC 32.5: Manufacture of medical and dental instruments and supplies;
• SIC 72.1: Research and experimental development on natural sciences and engineering.
Mechanical engineering:
• SIC 25: Manufacture of fabricated metal products, except machinery and equipment;
• SIC 26: Manufacture of computer, electronic and optical products EXCL 26.6;
• SIC 27: Manufacture of electrical equipment;
• SIC 28: Manufacture of machinery and equipment n.e.c.;
• SIC 29: Manufacture of motor vehicles, trailers and semi-trailers;
• SIC 30: Manufacture of other transport equipment;
• SIC 33: Repair and installation of machinery and equipment.
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